Daiichi Sankyo Europe GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.daiichi-sankyo.eu
Clinical Trials
76
Active:70
Completed:6
Trial Phases
1 Phases
Phase 1:37
Drug Approvals
13
NMPA:7
EMA:6
Drug Approvals
Trastuzumab Deruxtecan for Injection
- Product Name
- 优赫得
- Approval Number
- 国药准字SJ20230005
- Approval Date
- Mar 24, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials
Phase 1
37 (100.0%)No trials found
News
No news found